Financial Results Overview
Consolidated Financial Results (₹ in millions)
Income Statement for Quarter Ended June 30, 2026:
- Revenue from operations: ₹19,634.83 (Q1 FY26: ₹15,389.42; Q4 FY26: ₹20,242.57)
- Other income: ₹143.23 (Q1 FY26: ₹98.94; Q4 FY26: ₹247.79)
- Total income: ₹19,778.06 (Q1 FY26: ₹15,488.36; Q4 FY26: ₹20,490.36)
Expenses:
- Employee benefits expense: ₹12,275.91 (Q1 FY26: ₹9,872.10; Q4 FY26: ₹12,768.89)
- Finance costs: ₹218.92 (Q1 FY26: ₹274.08; Q4 FY26: ₹220.99)
- Depreciation and amortization: ₹1,280.26 (Q1 FY26: ₹1,181.88; Q4 FY26: ₹1,241.54)
- Other expenses: ₹2,977.30 (Q1 FY26: ₹2,056.43; Q4 FY26: ₹2,627.10)
- Total expenses: ₹16,752.39 (Q1 FY26: ₹13,384.49; Q4 FY26: ₹16,858.52)
Profitability:
- Profit before exceptional items and tax: ₹3,025.67 (Q1 FY26: ₹2,103.87; Q4 FY26: ₹3,631.84)
- Exceptional item: ₹150.89 (Q1 FY26: nil; Q4 FY26: nil)
- Profit before tax: ₹2,874.78 (Q1 FY26: ₹2,103.87; Q4 FY26: ₹3,631.84)
- Tax expense: ₹706.67 (Q1 FY26: ₹618.28; Q4 FY26: ₹1,054.57)
- Profit for the period: ₹2,168.11 (Q1 FY26: ₹1,485.59; Q4 FY26: ₹2,577.27)
Other Comprehensive Income:
- Total other comprehensive income (net of tax): ₹445.99 (Q1 FY26: -₹2.09; Q4 FY26: ₹2,075.60)
- Total comprehensive income: ₹2,614.10 (Q1 FY26: ₹1,483.50; Q4 FY26: ₹4,652.87)
Earnings Per Share:
- Basic EPS: ₹0.46 (Q1 FY26: ₹0.32; Q4 FY26: ₹0.56)
- Diluted EPS: ₹0.46 (Q1 FY26: ₹0.32; Q4 FY26: ₹0.56)
Capital Structure:
- Paid-up equity share capital: ₹46,792.74 million (unchanged from previous periods)
Standalone Financial Results (₹ in millions)
Income Statement for Quarter Ended June 30, 2026:
- Revenue from operations: ₹5,389.59 (Q1 FY26: ₹4,726.61; Q4 FY26: ₹5,019.23)
- Other income: ₹168.39 (Q1 FY26: ₹69.49; Q4 FY26: ₹280.58)
- Total income: ₹5,557.98 (Q1 FY26: ₹4,796.10; Q4 FY26: ₹5,299.81)
Expenses:
- Employee benefits expense: ₹3,048.31 (Q1 FY26: ₹2,414.17; Q4 FY26: ₹2,831.29)
- Finance costs: ₹157.97 (Q1 FY26: ₹204.94; Q4 FY26: ₹158.87)
- Depreciation and amortization: ₹232.52 (Q1 FY26: ₹201.62; Q4 FY26: ₹226.43)
- Other expenses: ₹954.76 (Q1 FY26: ₹684.71; Q4 FY26: ₹1,108.29)
- Total expenses: ₹4,393.56 (Q1 FY26: ₹3,505.44; Q4 FY26: ₹4,324.88)
Profitability:
- Profit before exceptional items and tax: ₹1,164.42 (Q1 FY26: ₹1,290.66; Q4 FY26: ₹974.93)
- Exceptional item: ₹150.89 (Q1 FY26: nil; Q4 FY26: nil)
- Profit before tax: ₹1,013.53 (Q1 FY26: ₹1,290.66; Q4 FY26: ₹974.93)
- Tax expense: ₹253.77 (Q1 FY26: ₹323.32; Q4 FY26: ₹235.60)
- Profit for the period: ₹759.76 (Q1 FY26: ₹967.34; Q4 FY26: ₹739.33)
Other Comprehensive Income:
- Total other comprehensive income (net of tax): ₹325.60 (Q1 FY26: -₹4.03; Q4 FY26: -₹531.06)
- Total comprehensive income: ₹1,085.36 (Q1 FY26: ₹963.31; Q4 FY26: ₹208.27)
Earnings Per Share:
- Basic EPS: ₹0.16 (Q1 FY26: ₹0.21; Q4 FY26: ₹0.16)
- Diluted EPS: ₹0.16 (Q1 FY26: ₹0.21; Q4 FY26: ₹0.16)
Capital Structure:
- Paid-up equity share capital: ₹46,792.74 million (unchanged from previous periods)
Key Performance Indicators (From Press Release)
Quarterly KPIs (Q1 FY27):
- Revenue: ₹19,635 million (27.6% YoY growth)
- Steady state revenue: ₹19,635 million
- Revenue by vertical: Payer ₹17,585 million (29.3% YoY), Provider ₹2,050 million (14.4% YoY)
- Reported EBITDA: ₹4,525 million (27.1% YoY), margin 23.0%
- Adjusted EBITDA: ₹4,716 million (27.9% YoY), margin 24.0%
- Adjusted PAT: ₹2,697 million (35.1% YoY), margin 13.7%
- Basic EPS: ₹0.46 (45.9% YoY growth)
- Adjusted Basic EPS: ₹0.58 (35.1% YoY growth)
- Total employees: 47,307 (18.5% YoY growth)
- Voluntary attrition rate: 28.6% (annualized)
TTM KPIs (June 2026):
- Revenue: ₹76,174 million (29.4% YoY growth)
- Reported EBITDA: ₹19,548 million (31.0% YoY)
- Profit after tax: ₹9,930 million (49.2% YoY)
- Adjusted PAT: ₹12,006 million (38.7% YoY)
Business Updates and Strategic Developments
CareSeed Acquisition:
- On June 11, 2026, Sagility LLC acquired 100% equity interest in CareSeed LLC
- Total contractual consideration: USD 30.0 million (₹2,873.38 million)
- Includes contingent consideration of up to USD 12.5 million (₹1,197.24 million) linked to performance targets over three years
- Fair value of contingent consideration at acquisition: USD 5.1 million (₹485.57 million)
- Provisional purchase consideration: USD 21.2 million (₹2,032.51 million)
- Goodwill recognized: USD 15.7 million (₹1,507.58 million)
- Added 26 new clients through acquisition
Client and Business Development:
- Secured $35.3 million of steady-state ACV in Q1 FY27
- Added 27 clients in Q1 FY27 (including CareSeed)
- Total client base: 109 clients
- Presence in 5 countries with 29 delivery centers
Exceptional Items:
- ₹150.89 million recognized in Q1 FY27 due to past service cost from re-measurement of gratuity and leave encashment liabilities
- Resulted from revised minimum wage notifications by Karnataka (effective May 22, 2026) and Telangana (effective June 1, 2026) governments
- Similar exceptional item of ₹328.23 million recognized in FY26 due to New Labour Codes implementation
Dividend Information:
- Board proposed final dividend of ₹0.10 per equity share for FY26 at meeting on May 12, 2026
- Subject to shareholder approval at ensuing AGM
- If approved, would result in cash outflow of approximately ₹468.13 million
Regulatory and Compliance Information
Meeting Details:
- Board meeting held on July 21, 2026
- Commenced at 4:55 PM IST, concluded at 5:37 PM IST
- Results approved by Board and recommended by Audit Committee
Auditor Information:
- Limited review conducted by B S R & Co. LLP (Firm Registration No.: 101248W/W-100022)
- Unmodified review reports issued for both standalone and consolidated results
- Signed by Hemanth Bhasin, Partner (Membership No.: 235040)
Subsidiary Information:
- Consolidated results include 18 subsidiaries as listed in Annexure I
- Key subsidiaries: Sagility LLC, Sagility Technologies LLC, Sagility Operations Inc., Sagility (Jamaica) Limited, Sagility (US) Inc., Birch Technologies LLC, BroadPath Global LLC
Management Commentary
Ramesh Gopalan, Managing Director and Group CEO:
"Healthcare organizations are increasingly looking for partners that can combine healthcare expertise with technology, AI, and operational accountability to deliver measurable outcomes. We are seeing growing demand for outcome-oriented managed services engagements, and the early momentum behind Sagility Synchrony reinforces our belief that the future of healthcare operations lies in more integrated, intelligent operating models. Our acquisition of CareSeed further strengthens our capabilities in healthcare quality and expands our reach in the Medicare Advantage and mid-market segments."
Srinivas Mattapalli, Group Chief Financial Officer:
"We have started the year on a strong note, supported by healthy business momentum, resilient profitability and robust cash generation. Our performance reflects the strength of Sagility's healthcare-focused model, the depth of our client relationships and our strong execution across markets. With a strong balance sheet, healthy cash flows and clear strategic priorities, we remain well placed to invest in growth, strengthen our capabilities and drive sustainable long-term value for our stakeholders."
Additional Information
Segment Reporting:
- Company operates in one segment: "Business process management services"
- CODM identified as Mr. Ramesh Gopalan - Group Chief Executive Officer
Website Availability:
- Results available on BSE Limited website (www.bseindia.com)
- Results available on NSE website (www.nseindia.com)
- Results available on company website (www.sagilityhealth.com)
Recognition and Awards:
- Recognized as Major Contender in Healthcare Customer Experience Management and Revenue Cycle Management
- Recognized as Leader in Clinical and Care Management Business Process Transformation
- Ranked 11th among India's 100 Best Companies to Work For 2026
- Recognized by ET Edge as Best Organizations for Women